| [iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme |
2019-05-30 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. |
2019-04-17 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Reaches New Milestone – Now more than 9,900 European Life Science Deals Available at Life-Sciences-Europe.com". Bremen. |
2019-04-26 |
| [iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com
& Life-Sciences-Scandinavia.com". Bremen. |
2019-07-08 |
| [iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. |
2020-07-15 |
| [iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. |
2019-07-01 |
| [iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. |
2020-05-04 |
| [iito] Business Intelligence. (12/10/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. |
2020-12-10 |
| [iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen. |
2020-11-08 |
| [iito] Business Intelligence. (11/30/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen. |
2020-11-30 |
| [iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. |
2019-11-11 |
| [iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. |
2018-10-31 |
| [iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com
and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. |
2019-01-11 |
| Zur Rose Group AG. (7/16/20). "Press Release: Zur Rose Group Acquires TeleClinic, Germany's Leading Telemedicine Provider". |
2020-07-16 |
| Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. |
2019-06-25 |
| Zedira GmbH. (7/1/16). "Press Release: Dr. Falk Pharma GmbH and Zedira Enter a Phase 1b Clinical Trial for a Celiac Disease Drug". Freiburg & Darmstadt. |
2016-07-01 |
| Zedira GmbH. (5/2/17). "Press Release: Dr. Falk Pharma and Zedira Announce Completion of Phase 1b Clinical Trial of ZED1227 for the Treatment of Celiac Disease and Move on to Proof of Concept Study". Freiburg & Darmstadt. |
2017-05-02 |
| Zedira GmbH. (4/26/18). "Press Release: Dr. Falk Pharma and Zedira Announce Start of the Phase 2a Proof of Concept Study of ZED1227 for the Treatment of Celiac Disease". Freiburg & Darmstadt. |
2018-04-26 |
| Zedira GmbH. (11/30/16). "Press Release: Zedira Receives Funding by the German Government for the Development of Transglutaminase Inhibitors for the Treatment of Diabetic Nephropathy". Darmstadt. |
2016-11-30 |
| Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen. |
2017-07-03 |
| Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. |
2019-07-25 |
| Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. |
2019-07-22 |
| Yumab GmbH. (6/16/20). "Press Release: Corat Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program". Braunschweig. |
2020-06-16 |
| Yumab GmbH. (5/7/20). "Press Release: Yumab Identifies Promising Candidate for Covid-19 Antibody Therapy". Braunschweig. |
2020-05-07 |
| Yukin Therapeutics S.A.S.. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis. |
2019-06-04 |
| Ysios Capital. (10/18/16). "Press Release: Ysios Capital Raises €126,4 m ($140 m) for Its Second Fund, Ysios Biofund II Innvierte". Barcelona. |
2016-10-18 |
| Xoma Corporation. (8/25/17). "Press Release: Xoma Announces Transformational License Agreements for Gevokizumab and Its IL-1 beta Intellectual Property Portfolio". Berkeley, CA. |
2017-08-25 |
| Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. |
2019-11-04 |
| XL-protein GmbH. (7/26/17). "Press Release: Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation Technology to Develop Long-Acting Asparaginase Product Candidates". Freising. |
2017-07-26 |
| XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation Technology". Freising. |
2018-01-09 |
| Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. |
2017-01-05 |
| Xenikos B.V.. (5/24/16). "Press Release: Xenikos B.V. to Introduce Immunotherapy T-Guard to Potential Pharmaceutical Partners at BIO International Convention 2016". Nijmegen. |
2016-05-24 |
| Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. |
2019-02-05 |
| Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. |
2019-01-07 |
| Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. |
2017-11-15 |
| Xeltis AG. (1/31/17). "Press Release: FDA Gives Xeltis Go Ahead to Begin Trials in the USA". |
2017-01-31 |
| X-Biotix Therapeutics, Inc.. (7/1/19). "Press Release: X-Biotix Therapeutics Joins Antimicrobials Working Group". Washington, DC. |
2019-07-01 |
| WuXi AppTec. (4/15/16). "Press Release: WuXi AppTec Acquires Crelux". Munich. |
2016-04-15 |
| Wise S.r.l.. (5/25/17). "Press Release: Wise Srl Raises EUR 6.5 Million for Clinical Validation of Novel Neuroelectrodes for Brain Monitoring and Spinal Cord Stimulation". Milan & Berlin. |
2017-05-25 |
| Wilex AG. (9/27/16). "Press Release: Subsidiary Heidelberg Pharma Contracts Suisse CDMO Celonic for Antibody Cell Line Development and Antibody Production". Munich. |
2016-09-27 |
| Wilex AG. (9/19/16). "Press Release: Wilex AG – Subsidiary Heidelberg Pharma Signs Option Agreement with Max Delbrück Center". Munich. |
2016-09-19 |
| Wilex AG. (7/13/17). "Press Release: Wilex Reports on First Half-year". Munich. |
2017-07-13 |
| Wilex AG. (6/2/16). "Press Release: Wilex AG Announces Change on the Executive Management Board". Munich. |
2016-06-02 |
| Wilex AG. (6/19/17). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates". Munich. |
2017-06-19 |
| Wilex AG. (4/25/16). "Press Release: Wilex AG Successfully Completes Capital Increase". Munich. |
2016-04-25 |
| Wilex AG. (4/24/17). "Press Release: Wilex AG Plans Rights Issue Using Authorised Capital. Ad-hoc release [Not for distribution, publication or transmission in the USA, Canada, Japan and Australia]". Munich. |
2017-04-24 |
| Wilex AG. (4/12/17). "Press Release: Interim Management Statement on the First Three Months of 2017". Munich. |
2017-04-12 |
| Wilex AG. (2/6/17). "Press Release: Wilex AG Secures Financing Commitment from Its Main Shareholder Dievini". Munich. |
2017-02-06 |
| Wilex AG. (10/9/17). "Press Release: Wilex AG Announces Adjustment of Guidance [Ad-hoc release – Insider information pursuant to Article 17 MAR]". Ladenburg. |
2017-10-09 |
| Wilex AG. (10/9/17). "Press Release: Interim Management Statement for the First Nine Months of 2017". Munich. |
2017-10-09 |
| Wilex AG. (10/26/16). "Press Release: Wilex AG. Subsidiary Heidelberg Pharma and Nordic Nanovector Enter into Collaboration to Develop Novel Antibody Drug Conjugates (ADC)". Munich. |
2016-10-26 |
| Wilex AG. (10/13/16). "Press Release: Interim Management Statement on the First Nine Months of 2016". Munich. |
2016-10-13 |
| Wilex AG. (1/25/17). "Press Release: Subsidiary Heidelberg Pharma Exercises Option on BCMA Antibodies of the Max Delbrück Center and Signs License Agreement". Munich. |
2017-01-25 |
| Werum IT Solutions AG. (5/2/16). "Press Release: Pharma Tech Firms Werum IT Solutions and Zenith Technologies Announce Global MES Partnership". Lüneburg. |
2016-05-02 |
| Werum IT Solutions AG. (5/16/19). "Press Release: Jens Woehlbier Assigned as New CEO of Werum IT Solutions". Lüneburg. |
2019-05-16 |
| Werum IT Solutions AG. (3/1/17). "Press Release: Werum America Reinforces Key Account Relations with Experienced Pharma Manufacturing Specialist". Lüneburg & Parsippany, NJ. |
2017-03-01 |
| Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". |
2019-07-31 |
| Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. |
2020-01-08 |
| Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. |
2020-07-15 |
| Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. |
2017-06-22 |
| Waters Corporation. (6/1/18). "Press Release: Waters Technologies for Food Safety, Food Authenticity and Biomedical Research at ASMS 2018". Milford, MA. |
2018-06-01 |
| Waters Corporation. (5/16/16). "Press Release: Waters Corporation Presentation at the UBS Global Healthcare Conference to Be Webcast Live". Milford, MA. |
2016-05-16 |
| Waters Corporation. (4/10/18). "Press Release: Waters New Acquity UPLC Plus Series Sets New Performance Benchmarks". Milford, MA. |
2018-04-10 |
| Waters Corporation. (11/1/16). "Press Release: Waters and Sotax Group Sign Co-Marketing and Re-Seller Agreement". Milford, MA. |
2016-11-01 |
| Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. |
2020-01-13 |
| Warp Drive Bio, Inc.. (10/16/17). "Press Release: Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections". Cambridge, MA. |
2017-10-16 |
| Wacker Chemie AG. (9/13/18). "Press Release: Wacker Invests in Jena Biotech Site". Jena. |
2018-09-13 |
| Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. |
2020-07-28 |
| Wacker Chemie AG. (3/8/17). "Press Release: Wacker Biotech and Fresenius Medical Care Successfully Produce Antibody Fragment with Foldtec". Munic & Jena. |
2017-03-08 |
| Wacker Chemie AG. (2/3/21). "Press Release: Wacker Strengthens Biologics Business by Acquiring US-based Plasmid DNA Manufacturer Genopis". Munich & San Diego, CA. |
2021-02-03 |
| VTU Technology GmbH. (4/27/16). "Press Release: VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration". Grambach & Vienna. |
2016-04-27 |
| Voyager Therapeutics, Inc.. (1/22/19). "Press Release: Voyager Therapeutics Appoints Robert Hesslein as General Counsel". Cambridge, MA. |
2019-01-22 |
| Vor Biopharma, Inc.. (2/14/19). "Press Release: Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia". Boston, MA. |
2019-02-14 |
| Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. |
2020-03-04 |
| Voluntis S.A.. (12/18/19). "Press Release: Voluntis Announces New Pharma Collaboration in Oncology". Cambridge, MA & Paris. |
2019-12-18 |
| Voluntis S.A.. (11/23/20). "Press Release: Voluntis Successfully Completes a Capital Increase of €5.9 Million and Finalizes the Financing of Its Strategic Roadmap [Not for US, CA, AU or JP] Japan.". Cambridge, MA & Paris. |
2020-11-23 |
| Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). |
2019-08-29 |
| Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). |
2019-10-08 |
| Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. |
2020-01-14 |
| Vividion Therapeutics, Inc.. (5/19/20). "Press Release: Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases". San Diego, CA. |
2020-05-19 |
| Vividion Therapeutics, Inc.. (4/30/19). "Press Release: Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing". San Diego, CA. |
2019-04-30 |
| Vividion Therapeutics, Inc.. (2/24/21). "Press Release: Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs". San Diego, CA. |
2021-02-24 |
| Vivet Therapeutics S.A.S.. (5/4/17). "Press Release: Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases". Paris. |
2017-05-04 |
| Vivasure Medical Ltd.. (9/8/16). "Press Release: Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States". Galway. |
2016-09-08 |
| Vita 34 AG. (4/20/17). "Press Release: Vita 34 Concludes Purchase Agreement for the Entire Acquisition of Its Competitor Seracell Pharma AG". Leipzig. |
2017-04-20 |
| Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig. |
2019-02-08 |
| ViroVet N.V.. (1/27/17). "Press Release: Dr George Gunn, Former CEO of Novartis Animal Health, Appointed as Chairman at ViroVet". Leuven. |
2017-01-27 |
| Virometix AG. (3/12/20). "Press Release: Virometix Announces Initiation of Phase 1 Clinical Trial with Its V-306 Vaccine Candidate". Schlieren. |
2020-03-12 |
| Virometix AG. (2/1/19). "Press Release: Virometix AG Appoints New CEO". Schlieren. |
2019-02-01 |
| Virion Biotherapeutics Ltd.. (12/17/18). "Press Release: Virion Biotherapeutics Appoints Edwin Moses as Chairman of the Board and Guido Dietrich as Head of Manufacturing". London. |
2018-12-17 |
| ViraTherapeutics GmbH. (9/13/18). "Press Release: Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies". Ingelheim. |
2018-09-13 |
| ViraTherapeutics GmbH. (5/30/17). "Press Release: ViraTherapeutics Appoints Heinz Schwer as CEO". Innsbruck. |
2017-05-30 |
| ViraTherapeutics GmbH. (3/5/18). "Press Release: ViraTherapeutics Starts Second Oncolytic Virus Development Program with Boehringer Ingelheim". Innsbruck. |
2018-03-05 |
| Vir Biotechnology, Inc.. (10/18/17). "Press Release: Vir Biotechnology Builds Pipeline, Capabilities, and Lays Out Strategy to Address Serious Infectious Diseases". San Francisco, CA. |
2017-10-18 |
| ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. |
2019-11-28 |
| ViGeneron GmbH. (1/5/21). "Press Release: ViGeneron Signs Global Collaboration Agreement for Ophthalmic Gene Therapy Development". Munich. |
2021-01-05 |
| Vifor Pharma AG. (7/21/17). "Press Release: European Commission Approves Marketing Authorisation for Veltassa". |
2017-07-21 |
| Vifor Pharma AG. (5/23/18). "Press Release: VFMCRP and Cara Therapeutics to Develop and Commercialise CR845 Injection for Chronic Kidney Disease-associated Pruritus". |
2018-05-23 |
| Vifor Pharma AG. (2/14/17). "Press Release: Vifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases". |
2017-02-14 |
| Vifor Pharma AG. (11/09/20). "Press Release: Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications". St. Gallen & Uniondale, NY. |
2020-11-09 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Source
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
